P-selectin+ microparticles
complexP-selectin+ microparticles are released during platelet activation and mediate leukocyte adhesion at sites of arterial injury.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleP-selectin+ microparticles mark platelet activation and platelet–leukocyte interaction; predict cardiovascular events.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I75
C — confounder / Type-II48
A — assay feasibility58
E — evidence strength28
T1DI (composite)10
Specificity differential (R−C)+27.5
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Plasma (citrate for coagulation complexes)
Collection tube
Sodium citrate 3.2% (light blue-top) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich ELISA against neo-complex epitope
Reagent / substrate
Antibody pair recognizing the assembled complex
Platform
ELISA plate
Turnaround · availability
Research / send-out · Research/specialized
Literature evidence(1)
- Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.Thrombosis and haemostasis · 2017 · PMID 28424820 · doi